A detailed history of Kavar Capital Partners Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Kavar Capital Partners Group, LLC holds 5,473 shares of BAX stock, worth $181,758. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,473
Previous 6,098 10.25%
Holding current value
$181,758
Previous $203,000 1.97%
% of portfolio
0.03%
Previous 0.04%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$32.85 - $40.26 $20,531 - $25,162
-625 Reduced 10.25%
5,473 $207,000
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $187,581 - $216,749
-4,952 Reduced 44.81%
6,098 $260,000
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $175,197 - $215,198
5,525 Added 100.0%
11,050 $427,000
Q4 2022

Feb 10, 2023

SELL
$49.7 - $57.71 $1.47 Million - $1.71 Million
-29,655 Reduced 84.3%
5,525 $281,000
Q3 2022

Nov 08, 2022

SELL
$53.86 - $66.8 $107,827 - $133,733
-2,002 Reduced 5.38%
35,180 $1.9 Million
Q2 2022

Aug 09, 2022

SELL
$63.83 - $80.0 $75,319 - $94,400
-1,180 Reduced 3.08%
37,182 $2.39 Million
Q4 2021

Jan 27, 2022

SELL
$74.57 - $87.19 $14,913 - $17,438
-200 Reduced 0.52%
38,362 $3.29 Million
Q3 2021

Nov 01, 2021

SELL
$73.77 - $83.61 $23,975 - $27,173
-325 Reduced 0.84%
38,562 $3.1 Million
Q2 2021

Aug 02, 2021

SELL
$80.5 - $88.01 $16,100 - $17,602
-200 Reduced 0.51%
38,887 $3.13 Million
Q1 2021

May 13, 2021

SELL
$76.38 - $86.03 $129,845 - $146,251
-1,700 Reduced 4.17%
39,087 $3.3 Million
Q4 2020

Feb 05, 2021

BUY
$75.39 - $82.36 $3.07 Million - $3.36 Million
40,787 New
40,787 $3.27 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Kavar Capital Partners Group, LLC Portfolio

Follow Kavar Capital Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kavar Capital Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kavar Capital Partners Group, LLC with notifications on news.